Skip to main content

Gradient Capital Advisors, LLC

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 1727917 SAN DIEGO, CA

Position in REGN

as of Jun 30, 2026 · filed Jul 13, 2026
Position Value
$239,439
-$57,254 QoQ
Shares Held
384
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.20%
of 13F equity value
Holder Rank
#997
of 1,322 holders
Holding Since
Sep 2022
16 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in REGN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Gradient Capital Advisors, LLC holds $281,389 across 2 Biotechnology names. REGN ranks #1 (85.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 REGN
Regeneron Pharmaceuticals, Inc.
This page
384 $239,439

All Filings in REGN

Export CSV
16 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $239,439 384
2026-03-31 $296,693 384
2025-12-31 $296,398 384
2025-09-30 $216,473 385
2025-06-30 $201,600 384
2025-03-31 $243,544 384
2024-12-31 $273,534 384
2024-09-30 $403,676 384
2024-06-30 $403,595 384
2024-03-31 $369,596 384
2023-12-31 $337,263 384
2023-09-30 $316,016 384
2023-06-30 $275,919 384
2023-03-31 $315,521 384
2022-12-31 $277,052 384
2022-09-30 $264,526 384